Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
48.77
-2.06 (-4.05%)
At close: Aug 28, 2026, 4:00 PM EDT
48.81
+0.04 (0.08%)
After-hours: Aug 28, 2026, 7:30 PM EDT

Rapport Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Income
-137.16-111.48-78.31-34.79-11.62
Depreciation & Amortization
0.961.020.840.110.02
Asset Writedown & Restructuring Costs
----5.45
Loss (Gain) From Sale of Investments
-0.89-1.4-3.21-0.08-
Stock-Based Compensation
24.5918.8610.243.530.61
Other Operating Activities
2.322.038.031.390.38
Change in Accounts Payable
-0.382.22-0.350.861.58
Change in Other Net Operating Assets
14.021.29-2.071.80.05
Operating Cash Flow
-96.68-87.47-64.83-27.18-3.54
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Capital Expenditures
-0.47-0.62-2.41-1.64-0.31
Sale (Purchase) of Intangibles
-----5.45
Investment in Securities
-167.29-186.86-167.74-77.22-
Investing Cash Flow
-167.56-187.47-170.14-78.86-5.76

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Total Debt Issued
----8.73
Net Debt Issued (Repaid)
----8.73
Issuance of Common Stock
273.18270.79157.710.050.03
Repurchase of Common Stock
-0.01-0--0-
Other Financing Activities
-0.39---0.13-0.11
Financing Cash Flow
272.79270.79221.63145.1443.29

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Cash Flow
8.55-4.16-13.3439.133.99

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-97.15-88.09-67.23-28.82-3.85
Free Cash Flow Growth
-----
Free Cash Flow Per Share
-2.16-2.26-3.24-19.14-4.95
Levered Free Cash Flow
-56.02-54.17-44.47-17.43-
Unlevered Free Cash Flow
-56.02-54.17-44.47-17.43-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Change in Working Capital
13.353.5-2.422.651.62
SEC Filings: 10-K · 10-Q